Below is a summary of recent research on Acyl-Carnitine in children with Autism Spectrum Disorder and what it could mean for future research.
A group of researchers led by Dr. Richard Frye, Director of the Autism Research Program at Arkansas Children’s Hospital Research Institute, reviewed the laboratory results of children diagnosed with autism spectrum disorder (ASD) who underwent screening for metabolic disorders and found, for the first time, that 17% of the children with ASD demonstrated a unique pattern of acyl-carnitine abnormalities similar to that found in a rodent model of ASD. This could be a very significant contributing factor to symptoms associated with an ASD and can lead to targeted therapies that address this specific biological abnormality in this subset of children. A recent publication discusses these research findings, the potential causes of these abnormalities, and also addresses their possible relation to ASD pathology.
Check out this article at the link below.
http://www.nature.com/tp/journal/v3/n1/full/tp2012143a.html
↧
